Archive 2012


Drs Viive Howell and Emily Colvin hosted a tour of the cancer research lab for Cancer Council NSW supporters, 28th November, 2012

A/Professor Ross Davey was the invited speaker at RNSH Prostate Group, 15th November, 2012

Dr Viive Howell featured in the Cancer Council NSW video for ovarian cancer research “Sell It For Cancer – How Victoria Did Her Thing”, 12th October, 2012

Dr Amanda Hudson was awarded a travel fellowship to present her research on mesothelioma, the lethal asbestos-induced cancer, at an international meeting in USA. This led to invitations to collaborate with European experts in this malignancy, September 2012.

Dr Viive Howell was the invited speaker at the CanToo Training Session, Sydney Academy of Sport and Rec, Wakehurst Parkway Narrabeen, 22nd August, 2012

A/Professor Ross Davey was the invited speaker at Epping Probus group, 13th August, 2012

Associate Professor Nick Pavlakis was featured in News item on Lung Cancer Breakthrough, Channel Ten News (Sydney) 16th August 2012.

Dr Viive Howell appointed Research Director of Bill Walsh Labs, 13th August 2012.

Viive brings a wealth of experience and knowledge to the position. She has been the recipient of a number of fellowships and scholarships, including a NHMRC CJ Martin Overseas Biomedical Postdoctoral Research Fellowship and Cancer Institute NSW Early Career Development Fellowship. The quality and impact of her research has been recognised through numerous awards, publications, invited presentations and grants.

Viive is also actively involved in promoting cancer research on this campus through a variety of community engagement activities. Her commitment to the future of cancer research is evidenced by her supervision and mentoring of students, including 3 current PhD students and a number of previous Honours and Masters students.

Prior to joining the Bill Walsh Lab, Viive worked at the University of Michigan Medical School, USA, and more recently has been a key member of the Functional Genomics Laboratory, Kolling Institute working on research focused on ovarian cancer.

Viive’s research team, Dr Emily Colvin, Emily Fuller and PhD student Indhu Subramanian also joined the lab.

The Bill Walsh Labs welcomes visiting oncologist/scientist from China.

Medical oncologist Dr Yingchun Xu joined the lab on 4th June as a visiting scientist from Shanghai Renji Hospital, Shanghai JiaotongUniversity,School of Medicine, China. Dr Yingchun Xu is learning new skills in the laboratory while researching genetic susceptibility to the toxic effects of chemotherapy used to treat breast cancer. Personalising chemotherapeutic doses according to genetic markers will improve the quality of life for patients undergoing chemotherapy. Following Yingchun’s return to China, we hope that this work will expand to a multi-national collaborative project.

Rozelle Harvie and Dr Amanda Hudson joined Cure Cancer Australia fundraisers for breakfast following a tour of the cancer research labs, 5th June 2012

Associate Professor Nick Pavlakis and Professor Stephen Clarke were invited speakers at the Kolling Knowledge Public Forum “Improving Cancer Care” 15th May 2012.

A/Professor Ross Davey visited Dubbo to thank Dubbo Rotary for their donations for the cancer vaccine project16th April,2012 with live interview on ABC regional radio by Dougal Saunders and  for Daily Liberal local Newspaper:

Dr Nick Pavlakis was promoted to Associate Professor in recognition of his outstanding commitment to medical oncology and cancer research, April 2012

Professor Stephen Clarke’s collaborator in his colorectal cancer research program, Dr Lucy Jankova, joined the lab early in 2012 to continue her research to distinguish patients who benefit from chemotherapy from those who would do well without such treatment. Medical student Joseph Chan joined the lab to also research colorectal cancer as a part-time Master of Philosophy student.

Australia Day Honour for cancer research and medical oncologist Professor Stephen Clarke

In the Australia Day Honours for 2012, Professor Stephen Clarke was awarded a Medal of the Order of Australia (OAM) for service to medicine in the disciplines of Oncology and Pharmacology.